Loading...
Loading...
India's plasma imports from UNITED STATES total $538.7M across 2,091 shipments from 15 foreign suppliers. CEVA ANIMAL HEALTH,LLC leads with $533.6M in import value; the top 5 suppliers together control 99.4% of this origin. Leading Indian buyers include CEVA POLCHEM PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for plasma — a diversified sourcing base with multiple active suppliers from UNITED STATES.

CEVA ANIMAL HEALTH,LLC is the leading Plasma supplier from UNITED STATES to India, with import value of $533.6M across 16 shipments. The top 5 suppliers — CEVA ANIMAL HEALTH,LLC, WATSON THERAPEUTICS INC., CELERION INC, VISTA BIOLOGICALS CORPORATION, CEVA ANIMAL HEALTHLLC — collectively account for 99.4% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CEVA ANIMAL HEALTH,LLC | $533.6M | 16 | 99.0% |
| 2 | WATSON THERAPEUTICS INC. | $836.9K | 362 | 0.2% |
| 3 | CELERION INC | $593.8K | 6 | 0.1% |
| 4 | VISTA BIOLOGICALS CORPORATION | $365.5K | 14 | 0.1% |
| 5 | CEVA ANIMAL HEALTHLLC | $357.0K | 2 | 0.1% |
| 6 | MEDIATECH INC | $335.2K | 19 | 0.1% |
| 7 | ICON | $258.5K | 7 | 0.0% |
| 8 | HDM LABS INC. | $227.0K | 5 | 0.0% |
| 9 | ATHENS RESEARCH & TECHNOLOGY | $221.9K | 27 | 0.0% |
| 10 | ZOETIS BELGIUM S A | $187.9K | 1 | 0.0% |
| 11 | GRIFOLS WORLDWIDE OPERATION LTD | $156.6K | 1 | 0.0% |
| 12 | JOHNSON RESEARCH LLC | $131.0K | 1 | 0.0% |
| 13 | BIOIVT,LLC | $105.0K | 6 | 0.0% |
| 14 | ICON LABORATORIES | $93.4K | 40 | 0.0% |
| 15 | MEDIATECH INC A CORNING SUBSIDIARY | $79.0K | 10 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CEVA POLCHEM PRIVATE LIMITED | $533.9M | 18 | 99.1% |
| 2 | VEEDA CLINICAL RESEARCH LIMITED | $1.1M | 332 | 0.2% |
| 3 | WATSON PHARMA PRIVATE LIMITED | $928.1K | 430 | 0.2% |
| 4 | YASHRAJ BIOTECHNOLOGY LIMITED | $464.2K | 28 | 0.1% |
| 5 | CORNING TECHNOLOGIES INDIA PRIVATE LIMITED | $397.0K | 33 | 0.1% |
| 6 | BHARAT SERUMS AND VACCINES LIMITED | $365.5K | 14 | 0.1% |
| 7 | KERRY INDEV LOGISTICS PRIVATE LIMITED | $187.9K | 1 | 0.0% |
| 8 | MYLAN LABORATORIES LIMITED | $179.3K | 18 | 0.0% |
| 9 | GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED | $156.6K | 1 | 0.0% |
| 10 | ACTIMUS BIOSCIENCES PRIVATE LIMITED | $131.3K | 7 | 0.0% |
| 11 | KRISHGEN BIOSYSTEMS PRIVATE LIMITED | $99.0K | 7 | 0.0% |
| 12 | CORNING TECHNOLOGIES INDIA PVT LTD | $88.3K | 11 | 0.0% |
| 13 | MERCK LIFE SCIENCE PRIVATE LIMITED | $57.2K | 56 | 0.0% |
| 14 | ICMR-REGIONAL MEDICAL RESEARCH CENTER | $54.9K | 1 | 0.0% |
| 15 | SIGMA ALDRICH CHEMICALS PRIVATE LIMITED | $46.2K | 92 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Plasma suppliers from UNITED STATES to India include CEVA ANIMAL HEALTH,LLC, WATSON THERAPEUTICS INC., CELERION INC. The leading supplier is CEVA ANIMAL HEALTH,LLC with import value of $533.6M USD across 16 shipments. India imported Plasma worth $538.7M USD from UNITED STATES in total across 2,091 shipments.
India imported Plasma worth $538.7M USD from UNITED STATES across 2,091 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Plasma sourced from UNITED STATES include CEVA POLCHEM PRIVATE LIMITED, VEEDA CLINICAL RESEARCH LIMITED, WATSON PHARMA PRIVATE LIMITED. The largest buyer is CEVA POLCHEM PRIVATE LIMITED with $533.9M in imports across 18 shipments.
The total value of Plasma imports from UNITED STATES to India is $538.7M USD, across 2,091 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,091 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists